TOKYO, May 08 (Pulse News Wire) – Anges,inc. (4563.T) reported its first quarter 2026 non-operating items ending March 31, 2026.
The company recorded interest income of ¥3.8 million from bank deposits and foreign exchange gains of ¥385.4 million due to fluctuations in currency rates affecting US dollar-denominated loans to subsidiary EmendoBio Inc. Additionally, AnGes incurred expenses related to stock issuance fees amounting to 2,163 thousand yen, primarily due to stamp duties and securities handling fees associated with warrant exercises. The company also recognized bond interest expense of ¥2.6 million from its second unsecured private placement bonds during the same period.
Furthermore, AnGes adjusted deferred tax assets based on a careful assessment of their recoverability, resulting in a tax adjustment of ¥2.8 million. Detailed figures for the quarter can be found in the company's interim earnings release disclosed today. --- For more comprehensive information, investors are advised to review the full interim earnings release for the December 2026 fiscal year first quarter, which was released concurrently with this notice.
🟢 Confidence: High AI-translated content.